# A2ML1

## Overview
A2ML1 is a gene that encodes the protein alpha-2-macroglobulin like 1 (α2ML1), which is a member of the alpha-2-macroglobulin (A2M) superfamily. This protein functions primarily as a protease inhibitor and is predominantly expressed in the epidermis, where it plays a critical role in regulating proteolytic activity during the final stages of keratinocyte differentiation (Galliano2006A). α2ML1 operates through a unique 'trap mechanism,' forming covalent complexes with various proteases, such as chymotrypsin and kallikrein 7, to inhibit their activity and maintain epidermal homeostasis (Nielsen2022CryoEM; Schepens2010The). The protein's structural features, including its macroglobulin domains and thioester bond formation, are essential for its function in the extracellular matrix (Nielsen2022CryoEM). Clinically, mutations in the A2ML1 gene have been associated with conditions such as otitis media and paraneoplastic pemphigus, highlighting its significance in disease pathogenesis (Nielsen2022CryoEM; Harwood2020α2Macroglobulinlike).

## Structure
The A2ML1 protein is a monomeric protease inhibitor belonging to the alpha-2-macroglobulin (A2M) superfamily. It is primarily found in the epidermal granular layer of the skin, as well as in the placenta, thymus, and testis (Nielsen2022CryoEM). Structurally, A2ML1 shares a common domain architecture with other A2MF proteins, including eight macroglobulin (MG) domains, a CUB domain, a thioester (TE) domain, and a linker (LNK) region with a bait region (BR) (Nielsen2022CryoEM). The MG domains are organized into two antiparallel β-sheets, while the CUB domain contains two β-sheets. The TE domain is an α-helical domain inserted within the CUB domain (Nielsen2022CryoEM).

The protein's structure is organized into two main units connected by the MG7 domain. The N-terminal residues form the MG-ring, and the C-terminal domains (CUB, TE, and MG8) form a compact structure called the CTM8 body (Nielsen2022CryoEM). The thioester and CUB domains associate through a conserved hydrophobic interface, and the TE and MG2 domains interact (Nielsen2022CryoEM). The MG8 domain becomes highly flexible upon cleavage, which is crucial for the protease-inhibitory mechanism (Nielsen2022CryoEM).

Post-translational modifications of A2ML1 include disulfide bond formation and N-glycosylation (Nielsen2022CryoEM). The protein does not have specific splice variant isoforms mentioned in the context (Nielsen2022CryoEM).

## Function
The A2ML1 gene encodes a protease inhibitor that is part of the α2-macroglobulin family, primarily expressed in the human epidermis. This protein, known as α2ML1, plays a crucial role in regulating proteolytic activity, particularly in the granular layer of the epidermis, which is the final stage of keratinocyte differentiation (Galliano2006A). A2ML1 functions by forming covalent complexes with various proteases, including chymotrypsin and kallikrein 7 (KLK7), thereby inhibiting their activity. This interaction is significant in the process of desquamation, as KLK7 is involved in the proteolysis of intercellular structures (Galliano2006A; Schepens2010The).

The protein operates through a 'trap mechanism,' where it binds to proteases, causing a conformational change that results in steric hindrance, preventing the proteases from accessing their substrates (Nielsen2022CryoEM; Schepens2010The). A2ML1 is also involved in maintaining epidermal homeostasis and may contribute to skin barrier function by regulating extracellular protease activity (Galliano2006A). The protein is secreted in the extracellular space, indicating its role in the extracellular matrix (Galliano2006A).

## Clinical Significance
Mutations and alterations in the A2ML1 gene have been linked to several diseases and conditions. Notably, mutations such as Arg730 and Phe733 in the A2ML1 gene have been genetically associated with otitis media, a common ear condition (Nielsen2022CryoEM). A2ML1 has also been implicated in the pathogenesis of paraneoplastic pemphigus, an autoimmune blistering disorder (Nielsen2022CryoEM; Harwood2020α2Macroglobulinlike). 

Increased serum levels of A2ML1 have been associated with paraneoplastic pemphigus, suggesting its involvement in inflammatory diseases (Kashiwagi2020Human). The gene's role as a protease inhibitor is crucial, and mutations or single nucleotide polymorphisms (SNPs) in the bait region of A2ML1 could affect its protease inhibitory function, potentially leading to autoimmune diseases (Kashiwagi2020Human). 

The A2ML1 protein's ability to conjugate and inhibit proteases through hydroxyl groups is a significant biochemical property, and alterations in this mechanism could impact its normal function, contributing to disease pathogenesis (Harwood2020α2Macroglobulinlike). These findings highlight the clinical significance of A2ML1 in various pathological conditions.

## Interactions
A2ML1 (alpha-2-macroglobulin like 1) is primarily known for its role as a protease inhibitor, interacting with various proteases through covalent conjugation. This interaction is facilitated by the formation of a thioester bond between A2ML1 and the protease, which is crucial for its inhibitory function (Nielsen2022CryoEM; Harwood2020α2Macroglobulinlike). A2ML1 can conjugate with proteases through hydroxyl groups, a process enhanced by the presence of a histidine residue at position 1084, which increases the reactivity of its thiol ester (Harwood2020α2Macroglobulinlike). This allows A2ML1 to inhibit proteases that lack primary amines, such as acetylated thermolysin (Harwood2020α2Macroglobulinlike).

The structural studies of A2ML1 reveal that upon protease interaction and bait region cleavage, A2ML1 undergoes significant conformational changes that expose the thioester domain, facilitating the trapping and inhibition of the protease (Nielsen2022CryoEM). These interactions are primarily related to its role in protease inhibition and do not involve direct interactions with nucleic acids (Nielsen2022CryoEM). A2ML1's interactions are crucial for its function in regulating protease activity, particularly in the skin and other tissues where it is expressed (Nielsen2022CryoEM).


## References


[1. (Harwood2020α2Macroglobulinlike) Seandean Lykke Harwood, Nadia Sukusu Nielsen, Kathrine Tejlgård Jensen, Peter Kresten Nielsen, Ida B. Thøgersen, and Jan J. Enghild. Α2-macroglobulin-like protein 1 can conjugate and inhibit proteases through their hydroxyl groups, because of an enhanced reactivity of its thiol ester. Journal of Biological Chemistry, 295(49):16732–16742, December 2020. URL: http://dx.doi.org/10.1074/jbc.ra120.015694, doi:10.1074/jbc.ra120.015694. This article has 7 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.ra120.015694)

[2. (Kashiwagi2020Human) Hirofumi Kashiwagi, Hitoshi Ishimoto, Sun-ichiro Izumi, Toshiro Seki, Rihito Kinami, Asako Otomo, Kazumi Takahashi, Fuyuki Kametani, Noriaki Hirayama, Erika Sasaki, Takashi Shiina, Kou Sakabe, Mikio Mikami, and Yoshie Kametani. Human pzp and common marmoset a2ml1 as pregnancy related proteins. Scientific Reports, March 2020. URL: http://dx.doi.org/10.1038/s41598-020-61714-8, doi:10.1038/s41598-020-61714-8. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-020-61714-8)

[3. (Schepens2010The) Isabelle Schepens, Fabienne Jaunin, Nadja Begre, Ursula Läderach, Katrin Marcus, Takashi Hashimoto, Bertrand Favre, and Luca Borradori. The protease inhibitor alpha-2-macroglobuline-like-1 is the p170 antigen recognized by paraneoplastic pemphigus autoantibodies in human. PLoS ONE, 5(8):e12250, August 2010. URL: http://dx.doi.org/10.1371/journal.pone.0012250, doi:10.1371/journal.pone.0012250. This article has 92 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0012250)

[4. (Galliano2006A) Marie-Florence Galliano, Eve Toulza, Hélène Gallinaro, Nathalie Jonca, Akemi Ishida-Yamamoto, Guy Serre, and Marina Guerrin. A novel protease inhibitor of the α2-macroglobulin family expressed in the human epidermis. Journal of Biological Chemistry, 281(9):5780–5789, March 2006. URL: http://dx.doi.org/10.1074/jbc.m508017200, doi:10.1074/jbc.m508017200. This article has 73 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m508017200)

[5. (Nielsen2022CryoEM) Nadia Sukusu Nielsen, Alessandra Zarantonello, Seandean Lykke Harwood, Kathrine Tejlgård Jensen, Katarzyna Kjøge, Ida B. Thøgersen, Leif Schauser, Jesper Lykkegaard Karlsen, Gregers R. Andersen, and Jan J. Enghild. Cryo-em structures of human a2ml1 elucidate the protease-inhibitory mechanism of the a2m family. Nature Communications, May 2022. URL: http://dx.doi.org/10.1038/s41467-022-30758-x, doi:10.1038/s41467-022-30758-x. This article has 7 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-022-30758-x)